Edward Scolnick

Last updated
Edward Scolnick
Alma mater
Known for Discovery of RAS pathway
Scientific career
Institutions

Edward Scolnick is a core investigator at the Broad Institute, the former founding director of the Stanley Center for Psychiatric Research at Broad Institute, and former head of research and development at Merck Research Laboratories.

Education and career

Scolnick earned a B.A. in 1961 from Harvard University and a M.D. in 1965 from Harvard Medical School. [1] After medical school, he joined the Public Health Service to avoid being drafted into the Vietnam War. [2]

During his 15 years at the NIH's National Cancer Institute, Scolnick discovered the RAS oncogene that is involved in the critical signaling pathway that shifts an otherwise normal cell into the aggressive cells known as tumor cells. His work helped establish the concept of blocking signaling pathways as fundamental to cancer biology and drug discovery.[ citation needed ]

Scolnick joined Merck in 1982 as executive director of virus and cell biology, after being recruited from the National Institutes of Health. He was head of Research at Merck Research Laboratories from 1985 until he stepped down in 2002. [3] While at Merck, he was involved in the development and introduction of 29 new medications and vaccines. [4]

He was a key figure in the development and marketing of Vioxx, which was pulled from the market after it was discovered that the drug caused a dangerously high risk of myocardial infarction. [4] Legal claims resulting from this have cost Merck billions. During the five years it was available in the US, more than 38,000 deaths were related to Vioxx use, and up to 25 million Americans took the drug. [5] In the subsequent investigations, it was revealed that it was likely that Merck knew about the adverse effects of the drug, and Scolnick had dismissed them in order to push the drug to market before Bayer's Celebrex. [6] [7]

Scolnick began as the founding director of the Stanley Center for Psychiatric Research at Broad Institute in 2007. In 2012, he stepped down as director and became the Stanley Center's chief scientist, being succeeded by Steven Hyman.

In 1980 he received the Eli Lilly and Company-Elanco Research Award from the American Society for Microbiology. He is an elected member of the National Academy of Sciences and its Institute of Medicine, and the American Academy of Arts and Sciences. He was also appointed to the Board of Visitors at the University of Pittsburgh School of Medicine.

MIT awards the Edward M. Scolnick Prize in Neuroscience in his honor. [8]

Related Research Articles

<span class="mw-page-title-main">National Institutes of Health</span> US government medical research agency

The National Institutes of Health, commonly referred to as NIH, is the primary agency of the United States government responsible for biomedical and public health research. It was founded in the late 1880s and is now part of the United States Department of Health and Human Services. Many NIH facilities are located in Bethesda, Maryland, and other nearby suburbs of the Washington metropolitan area, with other primary facilities in the Research Triangle Park in North Carolina and smaller satellite facilities located around the United States. The NIH conducts its own scientific research through the NIH Intramural Research Program (IRP) and provides major biomedical research funding to non-NIH research facilities through its Extramural Research Program.

<span class="mw-page-title-main">Cold Spring Harbor Laboratory</span> Private, non-profit research institution in US

Cold Spring Harbor Laboratory (CSHL) is a private, non-profit institution with research programs focusing on cancer, neuroscience, plant biology, genomics, and quantitative biology. It is located in Laurel Hollow on Long Island, New York.

The National Institute of Mental Health (NIMH) is one of 27 institutes and centers that make up the National Institutes of Health (NIH). The NIH, in turn, is an agency of the United States Department of Health and Human Services and is the primary agency of the United States government responsible for biomedical and health-related research.

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is one of the institutes and centers that make up the National Institutes of Health, an agency of the United States Department of Health and Human Services (HHS).

<span class="mw-page-title-main">Harold E. Varmus</span> American scientist (born 1939)

Harold Eliot Varmus is an American Nobel Prize-winning scientist. He is currently the Lewis Thomas University Professor of Medicine at Weill Cornell Medicine and a senior associate at the New York Genome Center.

<span class="mw-page-title-main">Broad Institute</span> Biomedical and genomic research center

The Eli and Edythe L. Broad Institute of MIT and Harvard, often referred to as the Broad Institute, is a biomedical and genomic research center located in Cambridge, Massachusetts, United States. The institute is independently governed and supported as a 501(c)(3) nonprofit research organization under the name Broad Institute Inc., and it partners with the Massachusetts Institute of Technology, Harvard University, and the five Harvard teaching hospitals.

<span class="mw-page-title-main">Erich Jarvis</span> American neuroscientist

Erich Jarvis is an American professor at Rockefeller University. He is the head of a team of researchers who study the neurobiology of vocal learning, a critical behavioral substrate for spoken language. By studying animals including songbirds, parrots, and hummingbirds, his research attempts to show that bird groups have similar learning abilities to humans in the context of sound, such as learning new sounds and then passing on vocal repertoires from one generation to the next. Jarvis focuses on the molecular pathways involved in the perception and production of learned vocalizations, and the development of brain circuits for vocal learning.

Steven Edward Hyman is Director of the Stanley Center for Psychiatric Research at the Broad Institute of MIT and Harvard in Cambridge, Massachusetts. He is also Harvard University Distinguished Service Professor of Stem Cell and Regenerative Biology. Hyman was Provost of Harvard University from 2001 to 2011 and before that Director of the U.S. National Institute of Mental Health (NIMH) from 1996 to 2001. Hyman received the 2016 Rhoda and Bernard Sarnat International Prize in Mental Health from the National Academy of Medicine for "leadership in furthering understanding and treatment of psychiatric disorders as biological diseases".

<span class="mw-page-title-main">Peter S. Kim</span> American scientist

Peter S. Kim is an American scientist. He was president of Merck Research Laboratories (MRL) 2003–2013 and is currently Virginia & D.K. Ludwig Professor of Biochemistry at Stanford University, Institute Scholar at Stanford ChEM-H, and Lead Investigator of the Infectious Disease Initiative at the Chan Zuckerberg Biohub.

Richard Lewis Huganir is a Bloomberg Distinguished Professor in the Departments of Neuroscience and Psychological and Brain Sciences, Director of the Solomon H. Snyder Department of Neuroscience, and co-director of the Johns Hopkins Medicine Brain Science Institute at the Johns Hopkins University School of Medicine. He has joint appointments in the Department of Biological Chemistry and the Department of Pharmacology and Molecular Sciences in the Johns Hopkins School of Medicine.

<span class="mw-page-title-main">Thomas R. Insel</span> American neuroscientist (born 1951)

Thomas Roland Insel is an American neuroscientist, psychiatrist, entrepreneur, and author who led the National Institute of Mental Health (NIMH) from 2002 until November 2015. Prior to becoming Director of NIMH, he was the founding Director of the Center for Behavioral Neuroscience at Emory University in Atlanta, Georgia. He is best known for research on oxytocin and vasopressin, two peptide hormones implicated in complex social behaviors, such as parental care and attachment. He announced on Sept. 15, 2015, that he was resigning as the director of the NIMH to join the Life Science division of Google X. On May 8, 2017, CNBC reported that he had left Verily Life Sciences. Insel is a Co-founder with Richard Klausner and Paul Dagum of a digital mental health company named "Mindstrong," a Bay-area startup. He has also co-founded Humanest Care, NeuraWell Therapeutics, and MindSite News and is a member of the scientific advisory board for Compass Pathways, a company that is developing the psychedelic drug psilocybin to treat depression and other mental health disorders. His book, Healing: Our Path from Mental Illness to Mental Health was published by Penguin Random House in February, 2022.

Samuel E. Gandy, is a neurologist, cell biologist, Alzheimer's disease (AD) researcher and expert in the metabolism of the sticky substance called amyloid that clogs the brain in patients with Alzheimer's. His team discovered the first drugs that could lower the formation of amyloid.

Utpal Banerjee is a distinguished professor of the department of molecular, cell and developmental biology at UCLA. He obtained his Bachelor of Science degree in chemistry from St. Stephen's College, Delhi University, India and obtained his Master of Science degree in physical chemistry from the Indian Institute of Technology, Kanpur, India. In 1984, he obtained a PhD in chemistry from the California Institute of Technology where he was also a postdoctoral Fellow in the laboratory of Seymour Benzer from 1984-1988.

<span class="mw-page-title-main">George Q. Daley</span> Medical academic

George Quentin Daley is the Dean of the Faculty of Medicine, Caroline Shields Walker Professor of Medicine, and Professor of Biological Chemistry and Molecular Pharmacology at Harvard Medical School. He was formerly the Robert A. Stranahan Professor of Pediatrics at Harvard Medical School, Director of the Stem Cell Transplantation Program at Boston Children's Hospital, and an investigator of the Howard Hughes Medical Institute, Associate Director of Children's Stem Cell Program, a member of the Executive Committee of the Harvard Stem Cell Institute. He is a past president of the International Society for Stem Cell Research (2007–2008).

<span class="mw-page-title-main">Peng Loh</span> American biochemist

Yoke Peng Loh is an American biochemist and molecular biologist currently acting as Senior Investigator and Head at the Section on Cellular Neurobiology, Laboratory of Developmental Neurobiology, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH). She earned a B.S. in biochemistry at University College Dublin in 1969 and a Ph.D. from the University of Pennsylvania in 1973. She did her postdoctoral work with Harold Gainer at NIH and at the Max Planck Institute in Germany.

The Stanley Center for Psychiatric Research at Broad Institute of MIT and Harvard is a multi-disciplinary biomedical research program located in Cambridge, Massachusetts that studies the biological basis of psychiatric disease.

<span class="mw-page-title-main">Judith L. Rapoport</span> American psychiatrist

Judith L. Rapoport is an American psychiatrist. She is the chief of the Child Psychiatry Branch at the National Institute of Mental Health (NIMH), part of the National Institutes of Health (NIH) in Bethesda, Maryland.

Joshua R Sanes is an American neurobiologist who is known for his contributions to the understanding of synapse development. Throughout his career, Sanes has been the recipient of various awards and honors, including membership to the U.S. National Academy of Sciences. His research involves an interdisciplinary approach which focuses mainly on the formation of synapses at the neuromuscular junction by combining the sciences of psychology, chemistry, biology, and engineering to study these circuits and employ molecular and genetic imaging to understand their function. Sanes currently lives in Boston, Massachusetts with his wife, Susan, and their two children.

<span class="mw-page-title-main">Marisela Morales (neuroscientist)</span> Mexican neuroscientist

Marisela Morales is a Mexican neuroscientist specializing in the neurobiology of drug addiction. She is a senior investigator at the National Institute on Drug Abuse.

<span class="mw-page-title-main">Morgan Sheng</span>

Morgan Hwa-Tze Sheng is a professor of neurobiology and a Core Institute Member at the Broad Institute, where he is a co-director of the Stanley Center for Psychiatric Research at Broad Institute. He is a professor of neuroscience in the Department of Brain and Cognitive Sciences as well as the Menicon Professor of Neuroscience at Massachusetts Institute of Technology. He is also an associate member at both The Picower Institute for Learning and McGovern Institute for Brain Research. He has served on the editorial boards of Current Opinions in Neurobiology, Neuron, and The Journal of Neuroscience.

References

  1. ↑ "Boston and San Francisco based Health Care and Life Science Investment Firm - Clarus". www.clarusfunds.com. Archived from the original on 2019-01-31. Retrieved 2016-12-05.
  2. ↑ "NCI Oral History Project, Interview with Edward Scolnick, M.D." (PDF). history.nih.gov. June 24, 1998. Archived from the original (PDF) on 2019-04-08. Retrieved 2017-05-19.
  3. ↑ "Edward M. Scolnick, M.D., Steps Down as President of Merck Research Laboratories and Member of Board of Directors, Returns to Laboratories - Evaluate". www.evaluategroup.com.
  4. 1 2 "Will Merck Survive Vioxx? - November 1, 2004". archive.fortune.com.
  5. ↑ "Vioxx - Uses, Side Effects, History and Market Withdrawal".
  6. ↑ "Merck's Fall from Grace - The Scientist Magazine®". The Scientist.
  7. ↑ Bowe, Christopher (20 June 2005). "Scolnick: retired but far from retiring" – via Financial Times.
  8. ↑ "Edward M. Scolnick Prize in Neuroscience - McGovern Institute for Brain Research at MIT". mcgovern.mit.edu.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.